0001384101-23-000134.txt : 20230724 0001384101-23-000134.hdr.sgml : 20230724 20230724170652 ACCESSION NUMBER: 0001384101-23-000134 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230719 FILED AS OF DATE: 20230724 DATE AS OF CHANGE: 20230724 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: JONES EVAN/ FA CENTRAL INDEX KEY: 0001020741 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36156 FILM NUMBER: 231105759 BUSINESS ADDRESS: STREET 1: 9000 VIRGINIA MANOR ROAD STREET 2: SUITE 206 CITY: BELTSVILLE STATE: MD ZIP: 20705 BUSINESS PHONE: 240-813-1260 MAIL ADDRESS: STREET 1: C/O OPGEN, INC. STREET 2: 708 QUINCE ORCHARD ROAD, SUITE 205 CITY: GAITHERSBURG STATE: MD ZIP: 20878 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: VERACYTE, INC. CENTRAL INDEX KEY: 0001384101 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071] IRS NUMBER: 205455398 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 6000 SHORELINE COURT, SUITE 300 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: (650) 243-6300 MAIL ADDRESS: STREET 1: 6000 SHORELINE COURT, SUITE 300 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 FORMER COMPANY: FORMER CONFORMED NAME: CALDEROME INC DATE OF NAME CHANGE: 20061219 4 1 wk-form4_1690232803.xml FORM 4 X0508 4 2023-07-19 0 0001384101 VERACYTE, INC. VCYT 0001020741 JONES EVAN/ FA 6000 SHORELINE COURT SUITE 300 SOUTH SAN FRANCISCO CA 94080 1 0 0 0 0 Common Stock 2023-07-19 4 S 0 838 30.1398 D 37601 D Common Stock 2023-07-19 4 S 0 3090 30.1723 D 35173 I by jVen Capital, LLC The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on June 11, 2022. Represents weighted average sales price. Sale prices for the transactions range from $30.01 to $30.26. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request. The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on December 12, 2022. Represents weighted average sales price. Sale prices for the transactions range from $30.01 to $30.28. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request. The Reporting Person is the sole managing member of jVen Capital, LLC. /s/ Jonathan Wygant, as attorney-in-fact 2023-07-24